---
title: "Clearmind Medicine (CMND) news: reverse split"
url: "https://aibio.space/companies/clearmind-medicine/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "CMND reverse split, convertible notes and merger news: Clearmind Medicine announces 1-for-10 reverse split, effective May 21, 2026. Clearmind Medicine Inc."
---

CMND Clearmind Medicine Inc. NASDAQ · Canada

# Clearmind Medicine (CMND) news CMND reverse split, convertible notes and merger news

Debt Financing · 2026-10-16

## [Clearmind Medicine to sell $2,000,000 of convertible notes for $1,800,000 in cash](https://aibio.space/news/clearmind-medicine-sell-2-000-000-convertible-notes-1-800-000-cash/)

The sale draws on an agreement allowing up to $10,000,000 of convertible promissory notes. The company expects it to close on or before October 19, 2026.

## Latest Clearmind Medicine news

1. 2026-09-30 Listings [Clearmind Medicine to effect 1-for-8 reverse share split, trading from October 5, 2026](https://aibio.space/news/clearmind-medicine-effect-1-8-reverse-share-split-trading-october-5/) Issued common shares will fall from 4,059,227 to 507,404, subject to fractional-share adjustments.
2. 2026-09-04 Mergers [Clearmind Medicine agrees to buy 51% of Charging Robotics for $2.5 million](https://aibio.space/news/clearmind-medicine-agrees-buy-51-percent-charging-robotics-2-5-million/) Clearmind will also lend Charging Robotics $1.5 million at 4% as a condition of closing, which is expected the week of September 7, 2026.
3. 2026-06-12 Debt Financing [Clearmind sells $1,000,000 of convertible notes at 90% of principal](https://aibio.space/news/clearmind-sells-1-000-000-convertible-notes-90-percent-principal/) Clearmind Medicine will issue $1,000,000 of convertible notes for $900,000 in cash, under a one-time exception to its own $2,500,000 quarterly limit. The agreement also amends the conversion price and sets a $1.875 floor price per share.
4. 2026-06-01 Debt Financing [Clearmind to issue $1,500,000 in convertible promissory notes](https://aibio.space/news/clearmind-issue-1-500-000-convertible-promissory-notes/) The notes carry a $1,500,000 principal amount and a cash purchase price of 90% of principal. The sale falls under an investor agreement amended in April 2026.
5. 2026-05-19 Listings [Clearmind Medicine announces 1-for-10 reverse split, effective May 21, 2026](https://aibio.space/news/clearmind-medicine-announces-1-10-reverse-split-effective-may-21-2026/) The split is part of the company's plan to regain compliance with Nasdaq's minimum bid price rule. Issued shares fall from 10,190,337 to about 1,019,033.
6. 2026-04-30 Debt Financing [Clearmind amends convertible note deal, leaving $10 million available](https://aibio.space/news/clearmind-amends-convertible-note-deal-leaving-10-million-available/) The amendment raises the subscription amount so that $10,000,000 of capacity remains for future convertible promissory notes.

## Clearmind Medicine at a glance

- **Ticker**: CMND

- **Listing**: NASDAQ

- **Country**: Canada

### Related companies

- [Optimi Health](https://aibio.space/companies/optimi-health/) CSE: OPTI
- [LUCY SCIENTIFIC DISCOVERY INC](https://aibio.space/companies/lucy-scientific-discovery/) OTC: LSDIF
- [BioNxt Solutions](https://aibio.space/companies/bionxt-solutions/) CSE: BNXT
- [Avicanna](https://aibio.space/companies/avicanna/) TSX: AVCN
- [HLS Therapeutics](https://aibio.space/companies/hls-therapeutics/) TSX: HLS
- [ME Therapeutics Holdings](https://aibio.space/companies/me-therapeutics/) CSE: METX
- [Devonian Health Group](https://aibio.space/companies/devonian-health/) TSXV: GSD
- [Arch Biopartners](https://aibio.space/companies/arch-biopartners/) TSXV: ARCH

### Also on NASDAQ

- [Regeneron Pharmaceuticals](https://aibio.space/companies/regeneron-pharmaceuticals/) REGN
- [Veru](https://aibio.space/companies/veru/) VERU
- [BioMarin Pharmaceutical](https://aibio.space/companies/biomarin-pharmaceutical/) BMRN
- [Kiora Pharmaceuticals](https://aibio.space/companies/kiora-pharmaceuticals/) KPRX
- [Pacira BioSciences](https://aibio.space/companies/pacira-biosciences/) PCRX
- [Greenwich LifeSciences](https://aibio.space/companies/greenwich-lifesciences/) GLSI

## Questions about Clearmind Medicine

Did Clearmind Medicine do a reverse stock split?

Our latest story on this, dated May 19, 2026: "Clearmind Medicine announces 1-for-10 reverse split, effective May 21, 2026". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/clearmind-medicine-announces-1-10-reverse-split-effective-may-21-2026/).

Has Clearmind Medicine sold convertible notes?

Our latest story on this, dated Oct 16, 2026: "Clearmind Medicine to sell $2,000,000 of convertible notes for $1,800,000 in cash". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/clearmind-medicine-sell-2-000-000-convertible-notes-1-800-000-cash/).

Is Clearmind Medicine involved in a merger or acquisition?

Our latest story on this, dated Sep 4, 2026: "Clearmind Medicine agrees to buy 51% of Charging Robotics for $2.5 million". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/clearmind-medicine-agrees-buy-51-percent-charging-robotics-2-5-million/).

What is the ticker symbol of Clearmind Medicine?

Clearmind Medicine Inc. trades under the ticker CMND on NASDAQ.

Where is Clearmind Medicine listed?

Clearmind Medicine Inc. is listed on NASDAQ.

What is the SEC CIK of Clearmind Medicine?

The SEC Central Index Key (CIK) for Clearmind Medicine Inc. is 1892500. Its filings are on SEC EDGAR.

How many shares does Clearmind Medicine have outstanding?

158,076 shares as of 2026-01-19, per the cover page of its 20-F filed 2026-01-20.

Which country or territory is Clearmind Medicine listed under?

Our directory records Clearmind Medicine Inc. under Canada.

What does Clearmind Medicine do?

Our directory classifies Clearmind Medicine Inc. as: Biopharma / pharmaceuticals. This is a directory classification, not a description of the pipeline.

What is the ISIN of Clearmind Medicine?

The ISIN recorded for Clearmind Medicine Inc. is CA1850537095.

Does aibio.space cover Clearmind Medicine?

aibio.space lists Clearmind Medicine Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is Clearmind Medicine incorporated?

SEC records list its state or country of incorporation as Z4.

What is the latest Clearmind Medicine (CMND) stock news?

Our latest story on Clearmind Medicine, dated Oct 16, 2026: "Clearmind Medicine to sell $2,000,000 of convertible notes for $1,800,000 in cash". The sale draws on an agreement allowing up to $10,000,000 of convertible promissory notes. The company expects it to close on or before October 19, 2026. [Source](https://aibio.space/news/clearmind-medicine-sell-2-000-000-convertible-notes-1-800-000-cash/).

How long will Clearmind Medicine's cash last?

From our story of Oct 16, 2026: It says its financial statements contain an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern. [Source](https://aibio.space/news/clearmind-medicine-sell-2-000-000-convertible-notes-1-800-000-cash/).

Is Clearmind Medicine a smaller reporting company?

SEC records list Clearmind Medicine Inc.'s filer category as: Non-accelerated filer<br>Emerging growth company.

## Investor discussion: Clearmind Medicine

Members talk about Clearmind Medicine (CMND). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Clearmind Medicine, newest first. Each line links the filing it comes from.

1. 2026-10-16 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026110220/ea0308756-6k_clearmind.htm)
2. 2026-09-30 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026105269/ea0306971-6k_clearmind.htm)
3. 2026-09-10 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026098779/ea030403301ex99-1.htm)
4. 2026-09-04 Mergers Reported a merger or acquisition agreement. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026097410/ea030401501ex99-1.htm)
5. 2026-09-02 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026096692/ea030445601ex99-1.htm)
6. 2026-06-15 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026068761/ea029277701ex99-1.htm)
7. 2026-06-12 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026068251/ea029459201ex99-1.htm)
8. 2026-06-01 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026063494/ea029301301-6k_clearmind.htm)
9. 2026-05-19 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026058701/ea029126901ex99-1.htm)
10. 2026-05-18 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026058428/ea0291357-6k_clearmind.htm)
11. 2026-04-30 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026050241/ea0288483-6k_clearmind.htm)
12. 2026-04-14 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026043518/ea0286336-6k_clearmind.htm)
13. 2026-03-12 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026026965/ea028034801ex99-1.htm)
14. 2026-02-17 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026017373/ea0277328-6k_clearmind.htm)
15. 2026-02-04 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390026012245/ea0275536-6k_clearmind.htm)
16. 2025-12-31 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390025126834/ea027140601ex99-1_clearmind.htm)
17. 2025-12-10 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390025120091/ea026911901ex99-1_clearmind.htm)
18. 2025-12-05 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390025118712/ea0268533-6k_clearmind.htm)
19. 2025-11-26 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390025115106/ea0267301-424b5_clearmind.htm)
20. 2025-11-13 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390025109567/ea0265392-424b5_clearmind.htm)
21. 2025-11-06 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390025107151/ea026434901ex99-1_clearmind.htm)
22. 2025-09-17 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390025088566/ea0257692-6k_clearmind.htm)
23. 2025-03-13 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1892500/000121390025023686/ea023323401ex99-1_clearmind.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:CMND on TradingView](https://www.tradingview.com/symbols/NASDAQ-CMND/).

## SEC filings and registration

- **SEC name**: Clearmind Medicine Inc.

- **CIK**: 1892500

- **Industry (SIC)**: Pharmaceutical Preparations (2834)

- **US tickers**: CMND (Nasdaq)

- **State or country of incorporation**: Z4

- **Fiscal year ends**: October 31

- **Filer category**: Non-accelerated filer<br>Emerging growth company

- **Business address**: 101-1220 WEST 6TH AVENUE, VANCOUVER, BRITISH COLUMBIA, Canada (Federal Level), V6H1A5

- **Phone**: 972-54-5704749

- **Shares outstanding**: 158,076 as of 2026-01-19 (20-F filed 2026-01-20)

### Recent filings (8-K and 6-K are the company's own announcements)

- [6-K](https://www.sec.gov/Archives/edgar/data/1892500/000121390026110220/ea0308756-6k_clearmind.htm) filed 2026-10-16
- [6-K](https://www.sec.gov/Archives/edgar/data/1892500/000121390026108644/ea0308337-6k_clearmind.htm) filed 2026-10-13
- [6-K](https://www.sec.gov/Archives/edgar/data/1892500/000121390026107727/ea0308056-6k_clearmind.htm) filed 2026-10-08
- [6-K](https://www.sec.gov/Archives/edgar/data/1892500/000121390026107425/ea0307943-6k_clearmind.htm) filed 2026-10-07
- [6-K](https://www.sec.gov/Archives/edgar/data/1892500/000121390026105269/ea0306971-6k_clearmind.htm) filed 2026-09-30
- [6-K](https://www.sec.gov/Archives/edgar/data/1892500/000121390026102371/ea0306375-6k_clearmind.htm) filed 2026-09-23
- [6-K](https://www.sec.gov/Archives/edgar/data/1892500/000121390026100943/ea0305826-6k_clearmind.htm) filed 2026-09-17
- [6-K](https://www.sec.gov/Archives/edgar/data/1892500/000121390026099433/ea0305390-6k_clearmind.htm) filed 2026-09-14

Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001892500), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

## Listing details

Clearmind Medicine Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CMND, recorded under Canada. The directory classifies it as Biopharma / pharmaceuticals. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Clearmind Medicine Inc.

- **Ticker**: CMND

- **Listing**: NASDAQ

- **Country or territory**: Canada

- **Business scope**: Biopharma / pharmaceuticals

- **ISIN**: CA1850537095

- **Last quote in directory**: 2026-10-21

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-CMND/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/clearmind-medicine/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Clearmind Medicine (CMND) news: reverse split", 2026-10-31, https://aibio.space/companies/clearmind-medicine/